I held this stock until earlier this year, however decided to...

I held this stock until earlier this year, however decided to step out and sit on the sidelines and allocate to some other nearer-term opportunities for the time being.Regarding the 200,000 review uptake in the US, I wasn't aware that they restated this target in the 4c as you mentioned (I couldn't see it in the report), however reaching this number by the end of the year does surprise me given the current growth rate. They've gone from 103,000 at the end of 2020 to 128,000 by 19th July 2021. It strikes me based on this growth rate that 200,000 which they hoped for will be near impossible to reach (unless I'm missing something).

Certainly not trying to downplay the opportunity because I think the potential could be huge like many here have expressed and I continue to keep a close eye on the stock for this reason. However, I'm not sure that that claimed profiles will grow at quite the rate we're hoping for.